Statistics for The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism
Total visits
| views | |
|---|---|
| The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism | 153 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| molecules-24-02192.pdf | 109 |
Top country views
| views | |
|---|---|
| United States | 109 |
| Sweden | 8 |
| Germany | 5 |
| Ukraine | 4 |
| China | 3 |
| Canada | 2 |
| United Kingdom | 2 |
| Russia | 2 |
| Lebanon | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 46 |
| Fairfield | 13 |
| Stockholm | 8 |
| White Plains | 7 |
| Houston | 6 |
| Jacksonville | 5 |
| Cambridge | 4 |
| Kiev | 4 |
| Kiez | 4 |
| Ann Arbor | 3 |
| Beijing | 2 |
| Brooklyn | 2 |
| Toronto | 2 |
| Anderson | 1 |
| Beirut | 1 |
| Gunzenhausen | 1 |
| Moscow | 1 |
| Mount Laurel | 1 |
| New York | 1 |
| Saint Petersburg | 1 |
| San Francisco | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Washington | 1 |